Gevorg Yaghjyan/LinkedIn
Apr 9, 2026, 14:46
Gevorg Yaghjyan: Advancing Research and Care for Transketolase Deficiency at Yale
Gevorg Yaghjyan, Project Leader at Parexel, shared a post on LinkedIn:
”New rare-disease research and clinical program has recently been launched at the Yale School of Medicine focusing on Transketolase (TKT) deficiency, an extremely rare genetic metabolic disorder.
The Yale Transketolase Deficiency Program was established to:
- Improve diagnosis of patients with this rare disorder
- Conduct cutting-edge research on the disease mechanism
- Develop future therapeutic strategies
- Provide multidisciplinary clinical care for patients with suspected or confirmed disease
The program is led by physicians and researchers including Andrew Wang and Anna Szekely at Yale.
It collaborates with major rare-disease networks such as:
the Undiagnosed Diseases Network
the National Organization for Rare Disorders (NORD)
to identify additional patients worldwide and accelerate research”
Stay updated with Hemostasis Today.
-
Sep 4, 2026, 02:44Ahmed Kotb: Emergency Management of Critical Bleeding in ITP
-
Sep 4, 2026, 02:30Mario Jimenez: KDIGO 2026 – A More Proactive Approach to IV Iron in Hemodialysis
-
Sep 4, 2026, 02:18Edgardo Alania: Edoxaban in Intracranial Haemorrhage Survivors with AF
-
Sep 3, 2026, 20:33Jennifer Weinstein: Happy to Share Our New Work on the Patient Experience in VWD at the NBDF Conference
-
Sep 3, 2026, 20:31Guillaume Courbon: New Publication on Erythroid-Produced FGF23 and Its Role in Anemia
-
Sep 3, 2026, 20:30Phuong Khanh Morrow: FDA Approval Marks an Important Step Forward for the PV Community
-
Sep 3, 2026, 20:29Sarah Robins: Happy to Share This Portrait Film I Voiced for the NNHHF
-
Sep 3, 2026, 20:27Mireille Muller: Europe Needs More Plasma Donors
-
Sep 3, 2026, 17:54Tareq Abadl: Extravascular Hemolysis The High-Yield Guide